Digitally Noted.

The article focuses on the transition from the use of paper notebook to electronic laboratory notebooks (ELN) for data management in pharmaceutical research and development in the U.S. It notes that the application of digital signatures is considered as one of the challenges due to the importance in complying intellectual property (IP) requirements. It cites the creation of digital signature standard by SAFE-BioPharma Association for the security of encryption on any electronic document.